Wat is renal tubular acidosis
Reading File
Now let me search the medical library and PubMed in parallel.
Finding Sources
Searching PubMed
"renal tubular acidosis"[MeSH Terms]
Good - found rich content in Comprehensive Clinical Nephrology and Brenner & Rector. Let me read the most relevant sections in parallel.
Reading File
Reading File
Let me get the comprehensive RTA content from Brenner & Rector block30 and block40, which have dedicated RTA sections.
Reading File
Reading File
Excellent detail from Brenner & Rector. Let me get more on Types I, II, and IV, plus treatment.
Reading File
Finding Sources
Let me get the Tintinalli treatment section and more detail on Type IV.
Reading File
Reading File
I now have comprehensive information from multiple authoritative sources. Let me compile the full answer.
Renal Tubular Acidosis (RTA)
Renal tubular acidosis (RTA) is a group of disorders characterized by hyperchloremic (normal anion gap) metabolic acidosis with a normal or near-normal GFR, caused by defects in the kidney's ability to reabsorb bicarbonate or excrete acid - not by a reduction in GFR itself.
Pathophysiology Overview
The kidney maintains acid-base balance via two main tubular mechanisms:
- Proximal tubule: reabsorbs ~85% of filtered HCO3-
- Distal nephron (collecting duct): secretes H+ via H+-ATPase on alpha-intercalated cells and generates new HCO3-
Defects in either process - or in aldosterone signaling - lead to the distinct RTA subtypes.
Classification of RTA
| Feature | Type I (Distal) | Type II (Proximal) | Type III (Mixed) | Type IV (Hyperkalemic) |
|---|---|---|---|---|
| Defect | Impaired H+ secretion in distal nephron | Reduced HCO3- reabsorption in proximal tubule | Both proximal + distal failure | Aldosterone deficiency or resistance |
| Serum K+ | Low (or normal) | Low (or normal) | Low | High |
| Urine pH | >5.5 (cannot acidify) | <5.5 (when not treated) | Variable | Low |
| Serum HCO3- | Very low | Moderate reduction (~15-18 mEq/L) | Low | Mild reduction |
| Anion gap | Normal | Normal | Normal | Normal |
| Stone/nephrocalcinosis | Yes | Rarely | No | No |
Type I - Distal RTA (Most Common)
Mechanism: Failure of alpha-intercalated cells in the collecting duct to secrete H+ (reduced H+-ATPase activity), so urine cannot be acidified below pH 5.5 even under maximal acid load.
Clinical features:
- Hypercalciuria, hypocitraturia
- Nephrolithiasis and nephrocalcinosis
- Failure to thrive, bone demineralization, rickets in children
- Hypokalemia (from loss of electrogenic H+ secretion, forcing K+ secretion to maintain electronegativity, plus increased aldosterone)
Genetic causes:
- ATP6V1B1 mutations (AR): nephrocalcinosis + sensorineural hearing loss
- ATP6V0A4 mutations (AR): nephrocalcinosis + late-onset hearing loss
- SLC4A1 (AE1 Cl-/HCO3- exchanger) mutations (AD, rarely AR): milder phenotype; may present in teens/adults; AR form can be associated with hemolytic anemia
Acquired causes: Sjogren syndrome (most common cause in adults), amphotericin B, autoimmune hepatitis, hypergammaglobulinemia, obstructive uropathy
Key test: Urine cannot acidify below pH 5.3 even after furosemide/fludrocortisone challenge or ammonium chloride load.
Type II - Proximal RTA
Mechanism: Reduced HCO3- reabsorption in the proximal tubule. Isolated proximal RTA is rare (genetic: SLC4A4 mutation causing loss of basolateral Na+-HCO3- cotransporter). More commonly it is part of Fanconi syndrome.
Fanconi syndrome features (generalized proximal tubule dysfunction):
- Glycosuria (with normal blood glucose)
- Hyperaminoaciduria
- Phosphate wasting (hypophosphatemia)
- Low-molecular-weight proteinuria
- Hypouricemia, hypercalciuria, hypokalemia, salt wasting
- Proximal RTA
Causes of Fanconi syndrome: tenofovir, cidofovir, adefovir, ifosfamide, aristolochic acid, multiple myeloma (light chains), Wilson disease, galactosemia, cystinosis
Key feature: Urine pH is <5.5 when off treatment (can still acidify distally), but becomes alkaline when given alkali (bicarbonate spills into urine once threshold is exceeded). Fractional excretion of HCO3- rises >15% with alkali loading.
Treatment requires large doses of alkali (up to 10 mEq/kg/day), because the proximal leak is severe. Use potassium citrate to avoid worsening hypokalemia. Also vitamin D and phosphate supplementation.
Type III - Mixed RTA (Rare)
Mechanism: Mutations in carbonic anhydrase II (CA2), required for both proximal HCO3- reabsorption and distal H+ secretion.
Features: AR inheritance; associated with osteopetrosis, cerebral calcifications, mental retardation, facial dysmorphism, conductive hearing loss, blindness.
Type IV - Hyperkalemic RTA
Mechanism: Aldosterone deficiency or resistance in the distal nephron. Aldosterone normally stimulates Na+ reabsorption and H+/K+ excretion; without it, both H+ and K+ accumulate.
Causes:
- NSAIDs, ACE inhibitors/ARBs, calcineurin inhibitors, K+-sparing diuretics
- Diabetic nephropathy (hyporeninemic hypoaldosteronism - most common acquired cause)
- Obstructive uropathy
- Chronic interstitial nephritis, sickle cell disease
- Pseudohypoaldosteronism (PHA) - genetic resistance to aldosterone
Key feature: Hyperkalemia + mild metabolic acidosis (less severe than Types I or II). Low urine pH (aldosterone absence reduces ammoniagenesis, not H+ pump function directly).
Treatment: Loop diuretics (furosemide) enhance distal Na+ delivery and acid excretion; fludrocortisone for mineralocorticoid deficiency; correct the hyperkalemia.
Diagnosis: Urine Anion Gap
A useful bedside tool for nonanion gap metabolic acidosis:
Urine Anion Gap = Urine Na+ + Urine K+ - Urine Cl-
- Negative UAG (Cl- > Na+ + K+): Appropriate ammonium (NH4+) excretion - suggests extra-renal cause (e.g., diarrhea) or Type II RTA (can still acidify)
- Positive UAG: Failure to excrete NH4+ - suggests distal (Type I) or Type IV RTA
Treatment Summary
| Type | Primary Treatment |
|---|---|
| Type I (Distal) | Potassium citrate (1-2 mEq/kg/day); thiazides + fluids to reduce stone risk |
| Type II (Proximal) | High-dose oral alkali (up to 10 mEq/kg/day); K+ citrate; phosphate + vitamin D for Fanconi |
| Type IV (Hyperkalemic) | Furosemide + fludrocortisone; stop offending drugs; treat hyperkalemia |
For all types: alkali therapy (bicarbonate or citrate) to normalize pH, and regular monitoring of serum potassium.
Sources: Brenner and Rector's The Kidney (9780323532655), Campbell-Walsh-Wein Urology (9780323546423), Tintinalli's Emergency Medicine (9781260019933)
This is a shared conversation. Sign in to Orris to start your own chat.